Fluvoxamine versus other anti-depressive agents for depression
نویسندگان
چکیده
منابع مشابه
Transcranial near-infrared phtobiomodulation causes anti-depressive and anti- anxiety effects in mice model of depression
Introduction: Depression is a common psychiatric disorder and about one in five people experience depression during their lifespan. Despite the anti-depressive effects of drug therapy, problems such as non-targeting and dose-resistant lead to more effective approaches. Transcranial Photobiomodulation (TPBM) or transcranial low-level laser (TLLL) therapy is a novel and neuropro...
متن کاملVortioxetine versus placebo for treatment of major depressive disorder
Introduction: Major depressive disorder is a common mental condition associated with substantial morbidity and economic burden. Approved by the FDA in September 2013 for treatment of episodes of major depressive disorder, Vortioxetine is one of the newer options available in this important area of therapeutics. Materials and methods: A comprehensive literature search (PubMed, the Cochrane libr...
متن کاملFluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison.
A double-blind, multinational study was conducted to compare the efficacy and safety of fluvoxamine and fluoxetine in outpatients with major depressive episode; 184 patients were randomised to fluvoxamine (100 mg/day) or fluoxetine (20 mg/day) for 6 weeks. Both drugs were effective and there were no statistically significant differences between them in the area under the curve of change from ba...
متن کاملAntifungal agents: Polyene, azole, antimetabolite, other and future agents
Antifungals have always been considered as one of the astonishing discoveries of the 20th century. This is correct, but the real marvel is the development of antifungal resistance in hospitals, communities, and the environment concomitant with their use. Fungal infections have emerged as an important clinical threat, with significant associated morbidity and mortality. This study is desig...
متن کاملFluvoxamine: a review of the controlled trials in depression.
Fluvoxamine, a serotonin selective reuptake inhibitor, has been available as an antiobsessional agent in the United States since 1995. However, it has been utilized as an effective antidepressant for many years in various European countries. The controlled trials of fluvoxamine in the pharmacotherapy of depression are reviewed. The drug compares well with a variety of other antidepressants. It ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2010
ISSN: 1465-1858
DOI: 10.1002/14651858.cd006114.pub2